2012 Oman heart association simplified guidelines for the management of patients with unstable angina/Non-ST-elevation myocardial infarction

Critical Pathways in Cardiology

Volumn 11, Issue 3, 2012, Pages 139-146

  El Deeb, Mohammed H ^a   Al Riyami, Abdullah M ^a   Al Riyami, Abdullah A ^a   Sulaiman, Kadhim J ^a   Shahrabani, Rashid ^a   Al Mukhaini, Mohamed ^a   Al Rawahi, Najib ^a   Al Riyami, Mohamed B ^a   Al Riyami, Adil B ^b   Sallam, Mansour ^b   Al Hinai, Said ^c   Al Wahshi, Yahia ^d   Panduranga, Prashanth ^a   Al Kharusi, Abdul Malik ^e  

^a MINISTRY OF HEALTH   (Oman)

^b SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

^c Diwan Medical Services   (Oman)

^d Armed Forces Hospital   (Oman)

^e Royal Oman Police Hospital   (Oman)

Author keywords

acute coronary syndrome; anti ischemic therapy; anti remodeling therapy; anticoagulant agents; antilipid agents; antiplatelet therapy; bleeding risk; coronary revascularization; ischemic risk

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANGRELOR; CLOPIDOGREL; DALTEPARIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; EPTIFIBATIDE; FELODIPINE; FONDAPARINUX; GLYCERYL TRINITRATE; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; MORPHINE SULFATE; NADROPARIN; NALOXONE; NIFEDIPINE; NITRATE; OMEPRAZOLE; PRASUGREL; TICAGRELOR; TICLOPIDINE; TIROFIBAN; TROPONIN; UNINDEXED DRUG; VERAPAMIL;

ARTICLE; BLEEDING; BLOOD TRANSFUSION; CARDIOVASCULAR MORTALITY; CLINICAL PRACTICE; DRUG DOSE INCREASE; DRUG ELUTING STENT; DRUG MEGADOSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EVIDENCE BASED MEDICINE; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE ORGANIZATION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HELICOBACTER INFECTION; HUMAN; HYPERTENSION; META ANALYSIS (TOPIC); MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATIENT CARE; PEPTIC ULCER; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPEATED DRUG DOSE; RESPIRATION DEPRESSION; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICOAGULANTS; CALCIUM CHANNEL BLOCKERS; ELECTROCARDIOGRAPHY; HUMANS; HYPOLIPIDEMIC AGENTS; OMAN; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; RISK ASSESSMENT; TROPONIN; VASODILATOR AGENTS;

EID: 84864376788     PISSN: 1535282X     EISSN: 15352811     Source Type: Journal    
DOI: 10.1097/HPC.0b013e31825ac653     Document Type: Article

References (24)

1. Anderson JL, Adams CD, Antman EM, et al. 2011 ACCF/AHA Focused Update Incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction. J Am Coll Cardiol. 2011;57;e215-e367.
2. Levine GN, Bates ER, Blankenship JC, et al. American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Society for Cardiovascular Angiography and Interventions. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58:e44-122.
3. Fitchett DF, Theroux P, Brophy JM, et al. Assessment and management of acute coronary syndromes (ACS): a Canadian perspective on current guideline-recommended treatment-Part 1: non-ST-segment elevation ACS. Can J Cardiol. 2011;27 Suppl A:S387-S401.
4. Hamm CW, Bassand J P, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2011;32:2999-3054.
5. Steg PG, Huber K, Andreotti F, et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J 2011;32:1854-1864.
6. Chew D P, Aroney CN, Aylward PE, et al. 2011 Addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes (ACS) 2006. Heart Lung Circ. 2011;20:487-502.
7. Cannon C P, Braunwald E. Unstable angina and non-ST elevation myocardial infarction. In: Bonow RO, Mann DL, Zipes DP et al., eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 9th ed. Philadelphia, PA: Saunders Elsevier; 2011.
8. Fuster V, Walsh R, Harrington R et al., eds., Hurst's The Heart, 13th ed., New York: McGraw-Hill, 2011.
9. Sakhuja R, Yeh RW, Bhatt DL. Anticoagulant agents in acute coronary syndromes. Curr Probl Cardiol. 2011;36:127-168.
10. Cannon C P. Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE): updated standing orders for ST-segment elevation myocardial infarction and unstable angina/non-ST-segment elevation myocardial infarction. Crit Pathw Cardiol. 2010;9:55-81.
11. Hanna EB, Rao S V, Manoukian S V, Saucedo JF. The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomes. JACC Cardiovasc Interv. 2010;3:1209-1219.
12. Galper BZ, Stant J, Reilly M, et al. Updating the chest pain algorithm: incorporating new evidence on emerging antiplatelet agents. Crit Pathw Cardiol. 2011;10:9-16.
13. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000;284:835-842. (Pubitemid 30643610)
14. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502. (Pubitemid 32758501)
15. Wiviott SD, Braunwald E, McCabe CH, et al. TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001-2015. (Pubitemid 350106708)
16. Wallentin L, Becker RC, Budaj A, et al. PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045-1057.
17. Yusuf S, Mehta SR, Chrolavicius S, et al. Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med. 2006;354:1464-1476.
18. Stone G W, McLaurin BT, Cox DA, et al. ACUITY Investigators. Bivalirudin for patients with acute coronary syndromes. N Engl J Med. 2006;355:2203-2216. (Pubitemid 44791162)
19. Cannon C P, Braunwald E, McCabe CH, et al. Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495-1504.
20. Schwartz GG, Olsson AG, Ezekowitz MD, et al. Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001;285:1711-1718. (Pubitemid 32259905)
21. Fox KA, Clayton TC, Damman P, et al. FIR Collaboration. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. J Am Coll Cardiol. 2010;55:2435-2445.
22. Mehta SR, Granger CB, Boden WE, et al. TIMACS Investigators. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med. 2009;360:2165-2175.
23. Montalescot G, Cayla G, Collet J P, et al. ABOARD Investigators. Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial. JAMA. 2009;302:947-954.
24. Riezebos RK, Ronner E, Ter Bals E, et al. OPTIMA trial. Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes. Heart. 2009;95:807-812.